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Abstract Bipolar disorder (BD) and attention deficit/
hyperactivity disorder (ADHD) may share common genetic
risk factors as indicated by the high co-morbidity of BD
and ADHD, their phenotypic overlap especially in pediatric
populations, the high heritability of both disorders, and the
co-occurrence in families. We therefore examined whether
known polygenic BD risk alleles are associated with
ADHD. We chose the eight best SNPs of the recent gen-
ome-wide association study (GWAS) of BD patients of
German ancestry and the nine SNPs from international
GWAS meeting a ‘genome-wide significance’ level of
a = 5 9 10-8. A GWAS was performed in 495 ADHD
children and 1,300 population-based controls using Hu-
manHap550v3 and Human660 W-Quadv1 BeadArrays.
We found no significant association of childhood ADHD
with single BD risk alleles surviving adjustment for mul-
tiple testing. Yet, risk alleles for BD and ADHD were
directionally consistent at eight of nine loci with the
strongest support for three SNPs in or near NCAN, BRE,
and LMAN2L. The polygene analysis for the BP risk alleles
at all 14 loci indicated a higher probability of being a BD
risk allele carrier in the ADHD cases as compared to the
controls. At a moderate power to detect association with
ADHD, if true effects were close to estimates from GWAS
for BD, our results suggest that the possible contribution of
BD risk variants to childhood ADHD risk is considerably
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lower than for BD. Yet, our findings should encourage
researchers to search for common genetic risk factors in
BD and childhood ADHD in future studies.
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Introduction
Differential diagnosis of bipolar disorder (BD) in pediatric
populations is difficult due to its overlap with disruptive
behavior disorders such as attention deficit/hyperactivity
disorder (ADHD; Holtmann et al. (2010) in Bipolar Dis-
order). In adults with BD, almost 20 % met criteria for
lifetime ADHD (McIntyre et al. 2010), in adolescents with
BD this rate was more than 70 %, and in prepubertal BD as
high as 98 % (Geller et al. 2000). The controversial dis-
cussion as to the existence of pediatric BD led to the
proposal of a ‘temper dysregulation with dysphoria’ (TDD)
category to be included into the mood disorder section of
DSM-V (APA; www.dsm5.org). The proposed TDD cri-
teria are highly congruent with those of the earlier defined
‘severe mood dysregulation’ syndrome (Leibenluft et al.
2003), and approximately 85 % of youth with severe mood
dysregulation meet criteria for ADHD (APA; www.dsm5.
org). Thus, it is likely that pediatric BD and ADHD share
some common genetic risk factors.
Recently, Landaas et al. (2011) as well as Weber et al.
(2011) examined whether relevant BD single nucleotide
polymorphisms (SNP) derived from BD genome-wide
association studies (GWAS) were associated with adult-
hood ADHD. Landaas and colleagues found no evidence
for an association in 561 Norwegian adults with ADHD,
while Weber and colleagues found evidence for association
of a haplotype in the diacylglycerol kinase gene (DGKH)
with BD, adulthood ADHD (n = 535) and unipolar
depression. Their studies were based on the assumptions
that both ADHD and BD were highly heritable, often co-
occurred in families (Birmaher et al. 2010), partly over-
lapped in phenotype, i.e., impaired impulse control, dys-
regulation of energy/activity level as well as mood
instability (Skirrow et al. 2009), and frequently co-occur-
red in adults (Wingo and Ghaerni 2007), and thus likely to
share some common genetic risk factors. Yet, adulthood
ADHD represents only a subgroup of the childhood ADHD
population, whose symptoms persists into adulthood
(40–50 %; Kessler et al. 2010).
Recently, Cichon et al. (2011) conducted a GWAS in 682
patients with BD and 1,300 controls, both groups of German
ancestry, and replicated their results in samples of European
ancestry summing up to 2,411 BD patients and 3,613 controls.
The primary aim of our current study was to examine whether
the best eight single nucleotide polymorphism (SNPs) alleles
found to be associated with BD by Cichon et al. (2011) were
also associated with childhood ADHD in a sample of 495
ADHD children of similar ancestry. The secondary aim was to
assess the association of SNP alleles with childhood ADHD,
which were found to be genome-wide significant for BD in
international GWAS (at p \ 5 9 10-8).
Materials and methods
Samples
The sample is based on a GWAS for childhood ADHD
(n = 495; Hinney et al. 2011). As the control sample of our
GWAS was the same as the one used by Cichon et al.
[(2011); controls 1], we re-analyzed our association results
for these SNPs using a second, independent control sample
(controls 2).
ADHD cases
Four hundred and ninety five children and adolescents with
ADHD (age range 6–18 years) were recruited and pheno-
typically characterized in six psychiatric in- and outpatient
units for children and adolescents (Aachen, Cologne,
Essen, Marburg, Regensburg, and Wu¨rzburg). Patients
were included if they were diagnosed with ADHD
according to DSM-IV (American Psychiatric Association
1994); the subtypes are given in Table 1. The ascertain-
ment strategy and inclusion criteria have been described
previously (Hinney et al. 2011; Hebebrand et al. 2006;
Schimmelmann et al. 2007). The socio-demographic and
diagnostic characteristics of the 495 children with ADHD
are displayed in Table 1.
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Controls 1
Thousand three hundred controls of German ancestry met
the quality control criteria (for details see Cichon et al.
2011); the control individuals were drawn from three
German population-based epidemiological studies: (a) the
Heinz Nixdorf Recall (Risk Factors, Evaluation of Coro-
nary Calcification, and Lifestyle) study (n = 383; Sch-
mermund et al. 2002), (b) PopGen (n = 490; Krawczak
et al. 2006), (c) KORA (n = 488; Wichmann et al. 2005).
The recruitment areas were Essen, Bochum, and Mu¨lheim
(Ruhr area) for (a), Schleswig-Holstein (Northern Ger-
many) for (b) and Augsburg (Southern Germany) for (c),
respectively.
Controls 2
A second independent sample of 1,133 controls of German
ancestry was derived from the population-based epidemi-
ological Heinz Nixdorf Recall study (Schmermund et al.
2002). The results pertaining to Control 2 for the markers
reported in Cichon et al. (2011) are provided in a supple-
mentary Table.
Written informed consent was given by all participants
and in case of minors by their parents. Studies were
approved by the respective institutional review boards or
ethics committees and conducted in accordance with the
Declaration of Helsinki.
SNP selection and genotyping
For the primary aim, we chose the eight best SNPs tagging
seven loci associated with BD according to the combined
analysis of Cichon et al. (2011), i.e., rs6547829, rs779279,
rs10278591, rs11764590, rs985409, rs2209263, rs9322993,
and rs1064395. For the secondary aim, we chose nine SNPs
tagging another seven loci from the meta-analysis by Chen
et al. (2013): rs6746896 in LMAN2L, rs7618915 at chro-
mosome 3p21, rs9834970 in TRANK1, and 4948418 in
ANK3; from the GWAS by Ferreira et al. (2008) supported
by the meta-analysis by Liu et al. (2011): rs10994336 and
rs1938526 in ANK3; from the GWAS by Sklar et al.
(2011): rs12576775 in ODZ4 and rs4765913 in CACNA1C;
and from the GWAS by Baum et al. (2008): rs1012053 in
DGKH.
The original GWAS analysis was performed using the
495 ADHD children and 1,300 controls (controls 1 sample;
see Hinney et al. 2011). Genome-wide genotyping was
performed on HumanHap550v3 and Human660 W-
Quadv1 BeadArrays (Illumina, San Diego, CA, USA) by
(i) Illuminas customer service, San Diego, CA, USA (all
PopGen controls); (ii) the Department of Genomics, Life
and Brain Center, University of Bonn, Germany (all
ADHD cases and Heinz Nixdorf Recall study controls) and
(iii) the Helmholtz Zentrum, Mu¨nchen, Germany (all
KORA controls). We applied a quality control (QC) pro-
tocol to filter genotypes and individuals to the overlapping
genotype content of all GWAS data sets. This QC protocol
has been previously described in detail (Hinney et al.
2011). It accounts for call rates (CR-cutoff 0.98 for SNPs
and 0.97 for individuals), heterozygosity, cross-contami-
nation, population stratification, relatedness, deviations
from Hardy–Weinberg equilibrium (HWE—cutoffs pexact-
cases \1 9 10
-6, pexact-controls \ 1 9 10
-4) and minor
allele frequencies (MAF—cutoff \1 % in cases or con-
trols). Moreover, we explored the cluster intensity plots of
the SNPs that were followed up manually by two inde-
pendent raters.
Statistical analysis
Genotype distributions in both ADHD cases and each of the
two control samples were tested for departure from Hardy–
Weinberg equilibrium by an exact test (all p[ 0.01 except
for rs12576775 where the exact two-sided p value was 0.001,
highlighted by footnote (e) in Table 2). We applied logistic
regression with (log-)additive allele coding to the BP SNPs
and report nominal two-sided p values based on Wald-type
Table 1 Clinical characteristics of children with ADHD (n = 495)
Probands n (%) or mean (SD)
Sex
Male 400 (80.8 %)
Female 95 (19.2 %)
Age 11.00 (SD 2.7)
Subtypesa
Predominantly inattentive 108 (21.8 %)
Predominantly hyperactive-
impulsive
25 (5.1 %)
Combined 362 (73.1 %)
Comorbiditiesa,b
Oppositional defiant disorder 167 (35.0 %)
Conduct disorder 56 (11.6 %)
Mood disorders likelyc 42 (8.7 %)
Anxiety disorders likelyd 191 (39.6 %)
a Current DSM-IV diagnosis according to K-SADS, Kinder-DIPS or
PACS
b Multiple scoring possible; information for 13 patients was missing
(i.e., 100 % pertain to n = 482)
c Diagnoses: major depressive disorder or dysthymic disorders
according to K-SADS/Kinder-DIPS, or mood disorder likely accord-
ing to PACS
d Diagnoses: generalized anxiety disorder, separation anxiety disor-
der, social phobia, specific phobias according to K-SADS/Kinder-
DIPS or anxiety disorder likely according to PACS
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Table 2 Frequencies of BD risk alleles in ADHD patients and controls (controls 1)
Chromosome
gene locus
SNP
(proxy, r2)a
Minor
allele
(A)
Frequency risk allele/genotype
frequencies (AA/AB/BB)
OR (95 % CI)
for minor
allele
pa, b OR from
literature
for minor
alleleb, c
References
ADHD patients Controls
2 BRE rs6547829 T 0.09 2/89/404 0.07 6/167/1127 1.41
(1.08–1.84)
0.011 1.32 Cichon et al.
(2011)
3 FGF12;
PYDC2
rs779279 A 0.47 106/251/
138
0.48 287/667/
336
0.95
(0.82–1.10)
0.468 0.86 Cichon et al.
(2011)
7 MAD1L1 rs10278591 T 0.22 21/177/297 0.21 60/420/820 1.08
(0.91–1.29)
0.376 1.21 Cichon et al.
(2011)
rs11764590 T 0.21 19/174/302 0.20 58/409/831 1.08
(0.90–1.28)
0.431 1.26 Cichon et al.
(2011)
7 LHFPL3 rs985409 G 0.42 90/231/167 0.38 194/610/
496
1.17
(1.00–1.35)
0.044 1.17 Cichon et al.
(2011)
9 TLE4; TLE1 rs2209263 A 0.26 39/182/274 0.30 120/545/
635
0.83
(0.70–0.97)
0.022 0.84 Cichon et al.
(2011)
14 SIP1 rs9322993 T 0.07 3/59/433 0.04 5/104/1191 1.51
(1.10–2.05)
0.009 1.37 Cichon et al.
(2011)
19 NCAN rs1064395 A 0.16 12/133/350 0.14 34/285/981 1.19
(0.97–1.45)
0.087 1.31 Cichon et al.
(2011)
2 LMAN2L rs6746896 G 0.33 48/232/215 0.37 179/610/
511
0.83
(0.71–0.97)
0.021 NAd, BD
risk allele
A
Chen et al. (2013)
3 3p21 rs7618915
(rs13094687,
0.96)
G 0.37 64/238/193 0.37 174/608/
518
1.01
(0.87–1.18)
0.911 NAd, BD
risk
allele G
Chen et al. (2013)
3 TRANK1 rs9834970
(rs1553656,
0.82)
T 0.46 103/251/
141
0.46 267/665/
368
1.00
(0.86–1.16)
0.980 NAd, BD
risk
allele C
Chen et al. (2013)
10 ANK3 rs4948418 T 0.07 0/70/428 0.07 7/167/1125 1.01
(0.75–1.34)
0.913 NAd, BD
risk
allele T
Chen et al. (2013)
rs10994336
(rs10994397,
1.00)
T 0.07 0/68/427 0.07 7/158/1135 1.04
(0.77–1.39)
0.785 1.45 Ferreira et al.
(2008)
rs1938526 C 0.07 0/72/423 0.07 8/163/1129 1.06
(0.79–1.41)
0.683 1.40 Ferreira et al.
(2008)
11 ODZ4 rs12576775e G 0.17 11/143/341 0.17 21/399/880 0.98
(0.80–1.20)
0.826 1.14 Sklar et al. (2011)
12 CACNA1C rs4765913
(rs4765914,
0.87)
T 0.19 17/155/323 0.19 40/413/846 1.01
(0.83–1.22)
0.937 1.14f Sklar et al. (2011)
13 DGKH rs1012053 C 0.15 12/123/360 0.16 29/355/907 0.92
(0.74–1.12)
0.396 0.63 Baum et al. (2008)
ANK3 ankyrinG; BRE brain and reproductive organ expressed; CACNA1C calcium channel, voltage dependent, L type, alpha 1C subunit; DGKH
diacylglycerol kinase, eta; FGF12 fibroblast growth factor 12; LHFPL3 lipoma HMGIC fusion partner-like 3; LMAN2L lectin, mannose-binding
2-like; MAD1L1 MAD1 mitotic arrest deficient-like 1; NCAN neurocan; ODZ4 odd Oz/ten-m homolog 4 (Drosophila); PALB2 partner and
localizer of BRCA2; PYDC2 pyrin domain containing 2; SIP1 survival of motor neuron protein interacting protein 1; TLE1/TLE4 transducin-like
enhancer of split 1/4; TRANK1 tetratricopeptide repeat and ankyrin repeat containing 1; CI confidence interval; NA not applicable; association
signals with nominal p values below 5 % in bold
a r2 based on 1000 Genomes Pilot 1; results are those reported for the proxy in case a proxy is provided
b Nominal two-sided p values
c For the originally reported SNP—switched to the minor allele effects where necessary by (1/OR)
d No OR reported by Chen et al. 2013; however, the BP risk allele was available
e Evidence for a violation of the Hardy–Weinberg equilibrium assumption exact p value (two-sided) in controls 0.001
f For the original SNP rs4765913 the minor allele A was the BD risk allele
1614 B. G. Schimmelmann et al.
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test statistics. The comparison-wise significance level a after
correction for multiple testing was set at 0.0035 (\0.05/14,
with 14 being the total number of loci tested). We used
QUANTO (http://hydra.usc.edu/GxE) for power calcula-
tion. The power was calculated for a level a of 0.0035 (two-
sided) under a (log-)additive inheritance mode for minor
allele frequencies between 4 and 50 % resembling those
reported in the original studies (see Table 2). In the absence
of risk allele effects for ADHD, we used an average effect
size of 1.50, given that effect sizes for BP risk allele effects
ranged from 1.14 to 2.08 (see Table 2). For a sample size of
495 ADHD cases and 1,300 controls, the power ranged
between *30 and 99 % for all tests. Thus, our study is
sufficiently powered to detect larger genetic effects for more
frequent variants. In addition to single SNP analyses, we
compared the risk alleles for directional consistency by one-
sided binomial sign tests and explored a polygenic score by
counting the unweighted number of BD risk alleles for each
of the 14 loci (for multiple SNPs per locus we randomly
selected one of them). The BD risk score was subsequently
plotted as overlaid histogram for ADHD cases and controls
(controls 1; see Fig. 1). Both BD risk score distributions
were compared using the two-sided Wilcoxon–Mann–
Whitney (WMW) test.
Results
Association study for BD risk alleles in ADHD
The results of the association analysis between BD risk
SNPs and childhood ADHD are displayed in Table 2. ORs
and nominal p values are reported. For comparison, the
odds ratios for the minor alleles reported in the original BD
GWAS are also listed. For the SNPs by Cichon et al.
(2011), a separate table with a comparison to an indepen-
dent control group (controls 2) has been included (sup-
plementary Table 1).
In detail, focusing on the BD SNP risk alleles reported by
Cichon et al. (2011), we detected evidence for an
association to ADHD with uncorrected p values of \0.05
for four SNPs when using the same controls as those used
by Cichon et al. (2011). In all these cases, the BD risk
alleles matched those associated with ADHD. None of these
association results survived control for multiple testing (at
a = 0.0035), and none of the findings using the second
control sample (controls 2) met nominal significance again
(supplementary Table 1). Only for the two coding SNPs in
NCAN and BRE, we observed a consistent risk allele pattern
across both control group comparisons (rs1064395 in
NCAN: ORcombined = 1.20, 95 % confidence interval
(0.99–1.44); rs6547829 in BRE: ORcombined = 1.34, 95 %
confidence interval (1.05–1.70)). Regarding the BD sus-
ceptibility SNPs of the other BD studies, our analyses
revealed suggestive evidence for association with ADHD in
rs6746896 near LMAN2L (Chen et al. 2013; uncorrected
p value 0.021) and no evidence for association with ADHD
for the remaining eight SNPs, which were found to be
genome-wide significant for BD in international GWAS (at
a = 5 9 10-8; Baum et al. 2008; Chen et al. 2013; Ferreira
et al. 2008; Liu et al. 2011; Sklar et al. 2011).
Directional effects and polygene BP risk score analysis
For seven of the eight SNPs implicated in BD by Cichon et al.
(2011), it was possible to compare the direction of BD effect
alleles and (potential) ADHD risk alleles. For six of these
seven SNPs (5/6 loci), we detected directionally consistent
effects on the risk of ADHD irrespective of the controls used
(one-sided binomial sign test, ploci = 0.02). The remaining
one SNP (rs779279) was not assessed because the ADHD
risk allele effect was smaller than 1.05 (indicating uncertain
direction of effect). Altogether, for nine of ten SNPs (8/9
loci) reported by Baum et al. (2008), Chen et al. (2013),
Cichon et al. (2011), Ferreira et al. (2008), and Sklar et al.
(2011), we detected directionally consistent effects on the
risk of ADHD (one-sided binomial sign test, ploci = 0.002).
Including the single SNP by Cichon et al. (2011) mentioned
above, seven SNPs were not assessed because the ADHD
risk allele effect was smaller than 1.05. Figure 1 displays the
overlaid histograms of the BD polygene risk score for ADHD
cases and controls (controls 1). The median number of BD
was ten for ADHD cases (1st quartile: 9; 3rd quartile: 12) and
ten for the controls (1st quartile: 8; 3rd quartile: 11),
respectively. Overall, ADHD cases had a higher probability
of being a BD risk allele carrier as compared to the controls
(pWMW = 6.42 9 10
-5).
Discussion
Clinical evidence has accumulated for potentially shared
genetic risk factors in BD and ADHD. Accordingly, we
Fig. 1 Overlaid histograms of the number of BD risk alleles
(possible range from 0 to 28) in ADHD patients and controls
(controls 1)
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hypothesized that the BD risk alleles found in genome-wide
association studies, particularly in the GWAS by Cichon et al.
(2011) in a sample of comparable ancestry, were relevant for
the ADHD phenotype. We re-analyzed our findings using a
second independent control sample, as our initial controls
were identical with the control sample in Cichon et al. (2011).
We found no significant association of childhood ADHD with
BD risk alleles surviving validation in a second independent
control sample or adjustment for multiple testing. However, in
three coding SNPs in NCAN, BRE and in one near LMAN2L,
risk allele patterns in BD were consistent with those observed
for ADHD. Notably, rs1064395 in NCAN was the only SNP
fulfilling the genome-wide significance criterion of
a = 5 9 10-8 in the study by Cichon et al. (2011). We
detected that the risk alleles for BD and ADHD were direc-
tionally consistent in eight out of the nine loci identified in the
study by Cichon et al. (2011) and all other BP studies.
Moreover, the polygene analysis for the BP risk alleles at all
14 loci indicated a higher probability of being a BD risk allele
carrier in the ADHD cases as compared to the controls.
Generally, large sample size and replication are man-
datory in genetic studies to minimize the risk of false
positive or negative findings (Albayrak et al. 2008). Our
study has relatively good power to detect an association
with ADHD, if the true effects are close to the estimates
from the GWA studies for BD. However, the study is
clearly underpowered to detect small to moderate effects
for lower MAFs. For example, focusing an OR of 1.3, all
other aspects held constant, leads to a range from 7 % (for
a MAF of 4 %) to 72 % (for a MAF of 50 %). Thus, while
our results suggest that the possible contribution of BD
genes to the risk of childhood ADHD is probably consid-
erably lower than for BD, the findings at least justify fur-
ther studies in larger samples on the putative shared genetic
risk factors of BD and childhood ADHD including gen-
ome-wide comparisons using a polygene approach as
recently shown in Berndt et al. (2013).
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